Thierry M. Jahan, MD
Medical Oncologist
Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Peritoneal Mesothelioma Pleural Mesothelioma
Dr. Thierry Jahan received his medical degree from the George Washington University School of Medicine. His residency was split between Cedars-Sinai Medical Center and UCLA, while he completed his fellowship at the University of California in San Francisco. Dr. Thierry Jahan is currently a lung cancer specialist at the UCSF Medical Center at Mount Zion, focusing on cancers such as mesothelioma. Dr. Jahan conducts studies towards more efficient treatment methods for mesothelioma and other related affections of the lungs, with numerous awards and publications detailing his findings.
Columbia University - 1983
Education
George Washington University School of Medicine - 1987
Medical School
Cedars-Sinai Medical Center/UCLA
Residency
Sinai Medical Center/ UCLA Division of General Internal Medicine; University of California at San Francisco
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
UCSF Medical Center at Mount Zion
Languages: English/Spanish
(888) 689-8273
1600 Divisadero St
San Francisco, California 94115
208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM)
Jahan T, Hassan R, Alley E, Kindler H, Antonia S, Whiting C, Coussens L, Murphy AL, Thomas A, Brockstedt DG. Results from a phase 1b trial. J Thorac Oncol.
See more >>A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.
Thomas S, Aggarwal R, Jahan T, Ryan C, Troung T, Cripps AM, Raha P, Thurn KT, Chen S, Grabowsky JA, Park J, Hwang J, Daud A, Munster PN. Ann Onc
See more >>Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma.
Tinkle CL, Weinberg V, Braunstein SE, Wustrack R, Horvai A, Jahan T, O\'Donnell RJ, Gottschalk AR.
See more >>Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity.
Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Am J Clin Oncol.
See more >>American College of Physicians
American Society of Clinical Oncology
Association of Northern California Oncologist
International Association for the Study of Lung Cancer
February 10, 2016
by Mike R.
Wait Time
Staff
Helpfulness
Knowledge
“Most of the time you have to wait for your appointment, but you have to understand that he spends as much time as you need when you are his patient. You are his priority and no one will ever rush you. He answered to all of my questions and made me feel comfortable with my treatment which is very important when someone deals with cancer. So you might have to wait, because he takes care of all of his patients.”